166 related articles for article (PubMed ID: 10697609)
1. Cyclin D1 is a possible predictor of sensitivity to chemoradiotherapy for esophageal squamous cell carcinoma.
Samejima R; Kitajima Y; Yunotani S; Miyazaki K
Anticancer Res; 1999; 19(6C):5515-21. PubMed ID: 10697609
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma.
Gotoh M; Takiuchi H; Kawabe S; Ohta S; Kii T; Kuwakado S; Katsu K
Jpn J Clin Oncol; 2007 Sep; 37(9):652-7. PubMed ID: 17940077
[TBL] [Abstract][Full Text] [Related]
3. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
Miyazaki T; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521
[TBL] [Abstract][Full Text] [Related]
4. [Effect of cyclin D1 protein expression on the prognosis of esophageal squamous-cell carcinoma treated with preoperative radiotherapy].
Zhu S; Zhai F; Yin W
Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):129-31. PubMed ID: 10920963
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitivity of squamous cell carcinoma metastases to the neck assessed by immunocytochemical profiling of fine-needle aspiration biopsy cell specimens: a pilot study.
Flezar MS; Kirbis IS; Popović KS; Strojan P
Radiother Oncol; 2009 Dec; 93(3):575-80. PubMed ID: 19850367
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical status of the p53 protein and Ki-67 antigen using biopsied specimens can predict a sensitivity to neoadjuvant therapy in patients with esophageal cancer.
Kitamura K; Saeki H; Kawaguchi H; Araki K; Ohno S; Kuwano H; Maehara Y; Sugimachi K
Hepatogastroenterology; 2000; 47(32):419-23. PubMed ID: 10791203
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
Okumura H; Natsugoe S; Matsumoto M; Yokomakura N; Uchikado Y; Takatori H; Ishigami S; Takao S; Aikou T
J Surg Oncol; 2005 Jul; 91(1):84-9. PubMed ID: 15999354
[TBL] [Abstract][Full Text] [Related]
8. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical characterization of p57KIP2 expression in human esophageal squamous cell carcinoma.
Matsumoto M; Furihata M; Ohtsuki Y; Sasaguri S; Ogoshi S
Anticancer Res; 2000; 20(3B):1947-52. PubMed ID: 10928132
[TBL] [Abstract][Full Text] [Related]
10. Biopsy specimen microvessel density is a useful prognostic marker in patients with T(2-4)M(0) esophageal cancer treated with chemoradiotherapy.
Hironaka S; Hasebe T; Kamijo T; Ohtsu A; Boku N; Yoshida S; Saitoh H; Ochiai A
Clin Cancer Res; 2002 Jan; 8(1):124-30. PubMed ID: 11801548
[TBL] [Abstract][Full Text] [Related]
11. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
[TBL] [Abstract][Full Text] [Related]
12. REG Ialpha is a reliable marker of chemoradiosensitivity in squamous cell esophageal cancer patients.
Hayashi K; Motoyama S; Sugiyama T; Izumi J; Anbai A; Nanjo H; Watanabe H; Maruyama K; Minamiya Y; Koyota S; Koizumi Y; Takasawa S; Murata K; Ogawa J
Ann Surg Oncol; 2008 Apr; 15(4):1224-31. PubMed ID: 18259819
[TBL] [Abstract][Full Text] [Related]
13. Concomitant analysis of p16/INK4, cyclin D1, and retinoblastoma protein expression in esophageal squamous cell carcinoma.
Nakamura T; Ide H; Eguchi R; Hayashi K; Takasaki K
Hepatogastroenterology; 2003; 50(53):1321-6. PubMed ID: 14571727
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma.
Perisanidis C; Perisanidis B; Wrba F; Brandstetter A; El Gazzar S; Papadogeorgakis N; Seemann R; Ewers R; Kyzas PA; Filipits M
J Oral Pathol Med; 2012 Jan; 41(1):40-6. PubMed ID: 21883486
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 overexpression in primary hypopharyngeal carcinomas.
Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S
Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of planned esophagectomy after neoadjuvant chemoradiotherapy for advanced esophageal carcinomas.
Kato H; Fukuchi M; Manda R; Faried A; Takita J; Nakajima M; Miyazaki T; Sohda M; Fukai Y; Masuda N; Tsukada K; Kuwano H
Anticancer Res; 2004; 24(6):4091-6. PubMed ID: 15736457
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of p53 protein associates decreased response to chemoradiotherapy in patients with esophageal carcinoma.
Yang B; Rice TW; Adelstein DJ; Rybicki LA; Goldblum JR
Mod Pathol; 1999 Mar; 12(3):251-6. PubMed ID: 10102609
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of prognostic factors of esophageal squamous cell carcinoma (stage II-III) after concurrent chemoradiotherapy using biopsy specimens.
Kii T; Takiuchi H; Kawabe S; Gotoh M; Ohta S; Tanaka T; Kuwakado S; Nishitani H; Katsu K
Jpn J Clin Oncol; 2007 Aug; 37(8):583-9. PubMed ID: 17709606
[TBL] [Abstract][Full Text] [Related]
19. P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy.
Lavertu P; Adelstein DJ; Myles J; Secic M
Laryngoscope; 2001 Nov; 111(11 Pt 1):1878-92. PubMed ID: 11801963
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of p53, p21 (Waf1/Cip1), and cyclin D1 protein expression in esophageal cancer patients.
Hirai T; Kuwahara M; Yoshida K; Osaki A; Toge T
Anticancer Res; 1999; 19(5C):4587-91. PubMed ID: 10650815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
